AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Egetis Therapeutics

Major Shareholding Notification Nov 11, 2020

3152_iss_2020-11-11_d5a8fb1c-3b6a-4330-b99f-bae0a8e427b2.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Egetis Therapeutics AB (publ)

Holder

Cidro Förvaltning AB

Instrument

Instrument Aktie
Before the transaction
Shares 6,767,379
Voting rights 6,767,379
Transaction
Reason for major shareholding notification Sell
Date 10/11/2020
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 5,367,379
Directly held voting rights 5,367,379
Indirectly held voting rights 5,367,379
Percentage
Directly held shares 4.6 %
Directly held voting rights 4.6 %
Indirectly held voting rights 4.6 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 9.2 % 5,367,379
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 9.2 % 5,367,379
Published
11/11/2020 13:16
Contact
Name
Peter Lindell
Phone
0708496659 Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.